SCHEMBL21047201

SCHEMBL21047201

CC(C)(C)OC(=O)N1CCC(COC(=O)c2ccccc2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.61
PKM P14618 1/20 0.61
CARM1 Q86X55 1/20 0.53
PRMT6 Q96LA8 1/20 0.53
GPR119 Q8TDV5 2/20 0.51
USP30 Q70CQ3 3/20 0.51
JAK2 O60674 1/20 0.49
JAK1 P23458 1/20 0.49
RAB9A P51151 1/20 0.49
CHRNB2 P17787 1/20 0.49
CHRNA5 P30532 1/20 0.49
CHRNA7 P36544 1/20 0.49
CHRNA4 P43681 1/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
STS P08842 1/20 0.47
NAMPT P43490 1/20 0.46
ACKR3 P25106 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19859549 1.00 KDM4E (0.61) KDM4EPKMCARM1PRMT6GPR119
SCHEMBL20245869 1.00 KDM4E (0.61) KDM4EPKMCARM1PRMT6GPR119
Hydrochloric Acid SCHEMBL21047384 0.99 KDM4E (0.60) KDM4EPKMCARM1PRMT6GPR119
Hydrochloric Acid SCHEMBL19859633 0.99 KDM4E (0.60) KDM4EPKMCARM1PRMT6GPR119
SCHEMBL4209884 0.94 KDM4E (0.65) KDM4EPKMCARM1PRMT6GPR119
SCHEMBL30544307 0.86 KDM4E (0.48) KDM4EPKMGPR119USP30JAK2
SCHEMBL30544343 0.86 KDM4E (0.48) KDM4EPKMGPR119USP30JAK2
SCHEMBL29223412 0.86 KDM4E (0.48) KDM4EPKMGPR119USP30JAK2
SCHEMBL18891231 0.85 KDM4E (0.64) KDM4EPKMGPR119RAB9AMEN1
SCHEMBL13876978 0.84 KDM4E (0.56) KDM4EPKMGPR119USP30JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190169181-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN, INC. 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169181-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME METAP2, DNPEP, FOLH1 KDM4E 2394/4885PKM 1598/4885CARM1 1978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.